Trial of Perioperative Endocrine Therapy - Individualising Care: FLT-PET sub-study

Trial Profile

Trial of Perioperative Endocrine Therapy - Individualising Care: FLT-PET sub-study

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Anastrozole (Primary) ; Letrozole (Primary) ; Antineoplastics
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms POETIC:FLT-PET
  • Most Recent Events

    • 11 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 19 Feb 2014 Accrual to date is 4% as reported by United Kingdom Clinical Research Network.
    • 19 Feb 2014 Planned End Date changed from 31 Dec 2013 to 17 Apr 2014 as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top